Fig. 3From: A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndromea Risk of bias graph. Review authors’ judgments about each risk of bias item presented as percentages across all included studies. b Risk of bias summary. Review authors’ judgments about each risk of bias item for each included studyBack to article page